The Mark Foundation for Cancer Research announced today the recipients of its Spring 2018 post-doctoral fellowships. In line with its mission of funding groundbreaking cancer research, MFCR has partnered with several non-profit organizations to support the work of post-doctoral researchers who are carrying out projects with the potential to deepen our understanding of cancer biology, and to accelerate cures from the bench to the patient.
The Mark Foundation for Cancer Research is funding a post-doctoral fellowship through a partnership with Life Sciences Research Foundation. Dr. Serge Gueroussov works in the laboratory of Dr. Feng Zhang at the Broad Institute of MIT and Harvard. His project involves the adaptation of CRISPR technology to make precise changes in RNA, in order to study how genes are expressed differently in cancer cells.
The Mark Foundation has also awarded a post-doctoral fellowship in partnership with the Cancer Research Institute. The awardee is Dr. Justin Perry, who works in the laboratory of Dr. Kodi Ravichandran at University of Virginia. Dr. Perry is studying how dead cancer cells are cleared from the body as well as the impact of this clean-up process on cancer therapy and the immune response.